- IITPL sets up plant for manufacturing of cath labs in Bengaluru
IITPL said it aims to manufacture 240 cath labs, which are both diagnostic and therapeutic medical equipment to treat cardio-vascular disea...
26 Oct, 2021, 05.44 PM IST
People with pre-existing medical conditions should avoid Shramik specials: Railway MinistryIt has been observed that some people who are availing this service have pre-existing medical conditions which aggravates the risk they fac...
29 May, 2020, 02.15 PM IST
47.7 per cent people living in Delhi slum found to be overweightAlmost 64.9% of 314 individuals who were assessed during a camp were found either over-weight or obese, which are important risk factors fo...
08 May, 2018, 11.42 PM IST
Want to be physically fit? Don't forget these 3 cardinal rulesThere are three tenets to greater physical fitness - strength, mobility and cardio-vascular health.
30 Dec, 2016, 02.11 PM IST
Orchid Pharma gets EIR report from USFDA on inspection closureOrchid Pharma has received Establishment Inspection Report (EIR) from the US health regulator on the successful inspection closure for its ...
31 Dec, 2015, 05.23 PM IST
Orchid Pharma unit inks pact with UK entity for $800 mn loanOrchid Pharma said its subsidiary has inked a pact with UK's Line Trust International to avail loan of up to $800 million (about Rs 5,300 c...
22 Dec, 2015, 09.01 PM IST
Orchid Chemicals in talks with banks for debt rejigDrug firm Orchid Chemicals & Pharmaceuticals is in talks with banks to convert its rupee debt into dollar-denominated one.
16 Sep, 2015, 02.43 PM IST
Orchid Chemicals surges 16% on USFDA approval for Gemifloxacin MesylateThe company is present in segments like anti-infective, anti-inflammatory, central nervous system, cardio vascular segment and other oral a...
18 Jun, 2015, 03.59 PM IST
Orchid Chemicals gets USFDA nod for anti-bacterial tabletsThe company has received approval from the United States Food and Drug Administration for its abbreviated new drug application for Gemiflox...
17 Jun, 2015, 07.01 PM IST
Laurus Labs gets Rs 550-cr investment from Warburg PincusWhile core promoters of Laurus led by Dr Chava Satyanarayana own majority stake of over 51% in the company, PE investors and global pharmac...
30 Oct, 2014, 04.10 AM IST
72% of corporate employees prone to heart diseaseDemanding schedules, high stress levels, lack of physical activity and poor eating habits are considered responsible for detoriation of hea...
27 Sep, 2012, 03.02 PM IST
- Orchid Chemicals gets USFDA nod for anti-bacterial tablets
Orchid Chemicals & Pharmaceuticals today said it has received approval from the US health regulator for generic Levofloxacin tablets.
06 Feb, 2012, 10.24 PM IST
- Ranbaxy Laboratories launches generic Cadeut in the American market
Drug firm Ranbaxy Laboratories on Tuesday launched a generic version of Caduet, used for treating cardio vascular diseases, in the US marke...
06 Dec, 2011, 05.34 PM IST
- RPG Life Sciences launches Impulse, boosts cardio-vascular portfolio
In its efforts to further spruce up its marketing set-up, RPG Life Sciences has launched its third vertical, Impulse, to focus on the growi...
17 Aug, 2010, 01.21 PM IST
- Lifestyle drugs witness double-digit growth
Lifestyle factors like physical inactivity, a salt-rich diet rich in fatty foods and smoking, are leading for an alarming increase in cardi...
04 Nov, 2008, 12.02 PM IST
- Flamingo expands CRAM pact with Israel co Teva
Mumbai-based Flamingo Pharmaceuticals has expanded its CRAM (contract research and manufacturing) agreement with Israel’s Teva Pharmaceutic...
02 Nov, 2007, 12.45 AM IST
- Indoco set to board NDDS platform
Mid-sized pharma company Indoco Remedies plans to start manufacturing novel drugs under the novel drug delivery system (NDDS) platform.
09 Apr, 2007, 01.35 AM IST